Cancer Research Horizons ^Investors

Cancer Research Horizons (CRT) is an organization that focuses on developing and commercializing new discoveries in cancer research. They bridge the gap between academia and industry, translating promising research into commercial propositions for the benefit of patients and financial gain. As a subsidiary of Cancer Research UK, the world's largest charitable funder of cancer research, CRT leverages their parent organization's extensive research and connections with leading institutions, pharmaceutical companies, and biotechs worldwide. With 30 years of experience in commercializing cancer research, CRT has a proven track record of successful innovation. Their dedicated and experienced workforce is split between drug discovery and commercialization, ensuring a comprehensive approach to bringing breakthrough therapeutics to patients.